PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 92 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,694,000 | -25.6% | 110,000 | -37.1% | 0.10% | +16.5% |
| Q3 2016 | $2,277,000 | -46.5% | 175,000 | -42.8% | 0.08% | -61.7% |
| Q2 2016 | $4,256,000 | +45.9% | 305,964 | +59.1% | 0.22% | +52.1% |
| Q1 2016 | $2,918,000 | +25.5% | 192,322 | +56.9% | 0.15% | +14.1% |
| Q4 2015 | $2,326,000 | +4.6% | 122,613 | +4.8% | 0.13% | +39.1% |
| Q3 2015 | $2,224,000 | +55.2% | 117,046 | +110.5% | 0.09% | +76.9% |
| Q2 2015 | $1,433,000 | – | 55,613 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |